Ventricular arrhythmias and QT-prolongation during therapy with ketanserin: report of a case.
A patient is reported who developed a marked prolongation of QTc and life threatening ventricular arrhythmias during oral Ketanserin therapy. No other factors contributing to the QTc prolongation or to the occurrence of ventricular arrhythmias were found. The relevant literature is reviewed.
Vandermotten
M
M
Department of Cardiology, University Hospital Gasthuisberg, Leuven, Belgium.
Verhaeghe
R
R
De Geest
H
H
D000284:Administration, Oral; D000368:Aged; D001145:Arrhythmias, Cardiac / Q000139:chemically induced*; D004562:Electrocardiography; D006801:Humans; D007650:Ketanserin / Q000008:administration & dosage / Q000009:adverse effects*; D008133:Long QT Syndrome / Q000139:chemically induced* / Q000503:physiopathology; D008297:Male; D013613:Tachycardia, Ectopic Junctional / Q000139:chemically induced* / Q000503:physiopathology; D013617:Tachycardia, Supraventricular / Q000139:chemically induced*
D007650:Ketanserin